In fact the results of our study would suggest that the application of exogenous polyamines has the potential to enhance the yield of in vitro generated insulin-producing β cells for the treatment of persons with diabetes, and is therefore an avenue of current investigation. This evidence concerns the gene INS and diabetes mellitus.